A
Andrew K. Burroughs
Researcher at Royal Free Hospital
Publications - 519
Citations - 41585
Andrew K. Burroughs is an academic researcher from Royal Free Hospital. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 97, co-authored 519 publications receiving 37992 citations. Previous affiliations of Andrew K. Burroughs include University College London & St. Vincent's Health System.
Papers
More filters
Journal ArticleDOI
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Jordi Bruix,Morris Sherman,Josep M. Llovet,Michel Beaugrand,Riccardo Lencioni,Andrew K. Burroughs,Erik Christensen,Luigi Pagliaro,Massimo Colombo,Juan Rodés +9 more
Journal ArticleDOI
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro,Josep M. Llovet,Rosalba Miceli,Sherrie Bhoori,M. Schiavo,Luigi Mariani,Tiziana Camerini,Sasan Roayaie,Myron Schwartz,Gian Luca Grazi,René Adam,Peter Neuhaus,Mauro Salizzoni,Jordi Bruix,Alejandro Forner,Luciano De Carlis,Umberto Cillo,Andrew K. Burroughs,Roberto Troisi,Massimo Rossi,Giorgio Enrico Gerunda,Jan Lerut,Jacques Belghiti,Ilka de Fátima Santana Ferreira Boin,Jean Gugenheim,Fedja Rochling,Bart van Hoek,Pietro Majno +27 more
TL;DR: More patients with hepatocellular carcinoma could be candidates for transplantation if the current dual approach to candidacy, based on the strict Milan criteria, were replaced with a more precise estimation of survival contouring individual tumour characteristics and use of the up-to-seven criteria.
Journal ArticleDOI
Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis
Vasiliki Arvaniti,Gennaro D'Amico,Giuseppe Fede,Pinelopi Manousou,Emmanuel Tsochatzis,M. Pleguezuelo,Andrew K. Burroughs +6 more
TL;DR: In patients with cirrhosis, infections increase mortality 4-fold; 30% of patients die within 1 month after infection and another 30% die by 1 year; prospects with prolonged follow-up evaluation and to evaluate preventative strategies are needed.
Journal ArticleDOI
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Cristina Ripoll,Cristina Ripoll,Roberto J. Groszmann,Roberto J. Groszmann,Guadalupe Garcia–Tsao,Guadalupe Garcia–Tsao,Norman D. Grace,Andrew K. Burroughs,Ramon Planas,Angels Escorsell,Juan Carlos Garcia Pagan,Robert W. Makuch,David Patch,Daniel S. Matloff,Jaime Bosch +14 more
TL;DR: HVPG, MELD, and albumin independently predict clinical decompensation in patients with compensated cirrhosis and with portal hypertension as determined by the hepatic venous pressure gradient.
Journal ArticleDOI
Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis
Roberto J. Groszmann,Guadalupe Garcia-Tsao,Jaime Bosch,Norman D. Grace,Andrew K. Burroughs,Ramon Planas,Angels Escorsell,Juan Carlos García-Pagán,David Patch,Daniel S. Matloff,Hong Gao,Robert W. Makuch +11 more
TL;DR: Nonselective beta-blockers are ineffective in preventing varices in unselected patients with cirrhosis and portal hypertension and are associated with an increased number of adverse events.